Dr. Lokendra Kumar Yadav

About Dr. Lokendra Kumar Yadav

Dr. Lokendra Kumar Yadav is a Senior Consultant Urologist at Marengo Asia Hospitals in Faridabad, India, with over 8 years of specialized experience in complex urological care. He holds postgraduate qualifications including MS (Master of Surgery) and MCh (Magister Chirurgiae) in Urology, the highest super-specialty credential in the field. His clinical expertise spans minimally invasive and robotic-assisted procedures, positioning him as a leader in modern urological treatment.

Dr. Yadav has developed particular depth in kidney transplantation—both deceased and living donor procedures—robotic uro-oncology, and advanced endoscopic interventions such as ureteroscopy and laser prostate surgery. He is skilled in managing the full spectrum of urological conditions, from benign prostatic hyperplasia and ureteral strictures to complex urological malignancies. His approach combines clinical precision with empathetic patient communication, ensuring that each treatment plan is tailored to individual needs and recovery goals.

He regularly treats international patients from the Gulf region, East Africa, and South Asia who seek advanced urological care at Marengo Asia. His fluency in English and Hindi, combined with the hospital's international patient services, makes the experience seamless for overseas visitors. Many patients value his detailed pre-operative consultations and post-operative follow-up via telemedicine, which allows continuity of care after return home.

Marengo Asia Hospitals is a multi-specialty institution accredited by leading national quality bodies and equipped with state-of-the-art robotic surgery suites, advanced imaging, and dedicated nephro-urology units. The hospital's location in the Delhi National Capital Region provides easy connectivity via Delhi airport. For international patients considering kidney transplantation or complex urological surgery, Dr. Yadav's combination of training, technology access, and patient-centered philosophy offers a compelling value proposition compared to Western centres, without compromise on clinical outcomes.